TNSN06113A1 - Antagonists of the bradykinin b1 receptor - Google Patents
Antagonists of the bradykinin b1 receptorInfo
- Publication number
- TNSN06113A1 TNSN06113A1 TNP2006000113A TNSN06113A TNSN06113A1 TN SN06113 A1 TNSN06113 A1 TN SN06113A1 TN P2006000113 A TNP2006000113 A TN P2006000113A TN SN06113 A TNSN06113 A TN SN06113A TN SN06113 A1 TNSN06113 A1 TN SN06113A1
- Authority
- TN
- Tunisia
- Prior art keywords
- present
- bradykinin
- antagonists
- receptor
- peptides
- Prior art date
Links
- 102000017916 BDKRB1 Human genes 0.000 title 1
- 108010044231 Bradykinin B1 Receptor Proteins 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 231100000676 disease causative agent Toxicity 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to certain biologically active peptides and conjugated peptides which can be used as therapeutics or prophylactics against diseases or conditions linked to B1 as the causative agent. In a preferred embodiment of the invention biologically active PEG-conjugated peptides are provided. In one aspect of the present invention, pharmacologically active PEG-conjugated peptides of the present invention are useful to treat inflammation or pain.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51391303P | 2003-10-22 | 2003-10-22 | |
| PCT/US2004/034976 WO2005042027A2 (fr) | 2003-10-22 | 2004-10-22 | Antagonistes du recepteur de la bradykinine b1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN06113A1 true TNSN06113A1 (en) | 2007-11-15 |
Family
ID=37610132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2006000113A TNSN06113A1 (en) | 2003-10-22 | 2006-04-20 | Antagonists of the bradykinin b1 receptor |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1897976A (fr) |
| TN (1) | TNSN06113A1 (fr) |
| ZA (1) | ZA200603912B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8592426B2 (en) * | 2011-01-24 | 2013-11-26 | Hoffmann—La Roche Inc. | Aryl-benzocycloalkyl amide derivatives |
| CN105085633B (zh) * | 2014-05-12 | 2019-10-08 | 复旦大学 | 具有缓激肽受体结合活性的多肽及其用途 |
| US11401303B2 (en) * | 2020-06-15 | 2022-08-02 | Taian City Qihang Biotechnology Co. | Synthetic peptide BRAP and application in preparation of anti-inflammatory drug for COVID-19 thereof |
-
2004
- 2004-10-22 CN CNA2004800381506A patent/CN1897976A/zh active Pending
- 2004-10-22 ZA ZA200603912A patent/ZA200603912B/en unknown
-
2006
- 2006-04-20 TN TNP2006000113A patent/TNSN06113A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1897976A (zh) | 2007-01-17 |
| ZA200603912B (en) | 2007-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG149872A1 (en) | Antagonists of the bradykinin b1 receptor | |
| BR0308090A (pt) | conjugados de agentes citotóxicos ou terapêuticos e peptìdios biologicamente ativos | |
| TW200605870A (en) | Topical methadone compositions and methods for using the same | |
| PT1587506E (pt) | Administração de capasaicinóides | |
| WO2005107726A3 (fr) | Procede pour le traitement de mal de dos | |
| MXPA05006670A (es) | Administracion de capsaicinoides. | |
| IL163725A0 (en) | Administration of agents for the treatment of inflammation | |
| CY1114448T1 (el) | Φαρμακευτικες συνθεσεις και χρηση αυτων στην αγωγη της γυναικειας σεξουαλικης δυσλειτουργιας | |
| WO2002099388A3 (fr) | Benzodiazepines antagonistes de bradykinine | |
| GB0700027D0 (en) | A combination composition | |
| ATE423114T1 (de) | Aminocyclopropancarbonsäureamidderivate als bradykininantagonisten | |
| WO2005082070A3 (fr) | Compositions et methodes de traitement systemique de l'arthrite | |
| TNSN06113A1 (en) | Antagonists of the bradykinin b1 receptor | |
| IL166596A0 (en) | Salt of morphine-6-glucoronide | |
| WO2005087792A3 (fr) | Materiaux et procedes relatifs au traitement des glioblastomes | |
| EP1741430A4 (fr) | Remède pour maladies psycho névrotiques | |
| WO2004012732A3 (fr) | Utilisation d'un inhibiteur du proteasome dans le traitement du dysfonctionnement endothelial et/ou dans le cadre d'une therapie a base de proteasome a faible dose | |
| IL174134A0 (en) | Use of a protein in the preparation of a medicament for treatment of fibrotic diseases | |
| GB0304549D0 (en) | Biologically and therapeutically active agents against HIV-1 | |
| GB0410138D0 (en) | Biologically and therapeutically active agents against HIV-1 | |
| GB0218483D0 (en) | Biologically and therapeutically active agents against HIV-1 | |
| MX2009001631A (es) | Formulacion farmaceutica para el tratamiento de afecciones en la piel. | |
| HK1073999A (en) | Conjugates of therapeutic or cytotoxic agents and biologically active peptides | |
| GB0305644D0 (en) | Biologically and therapeutically active agents | |
| GB0306345D0 (en) | Biologically and therapeutically active agents |